R. Lynen

748 total citations
45 papers, 528 citations indexed

About

R. Lynen is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, R. Lynen has authored 45 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Public Health, Environmental and Occupational Health, 17 papers in Hematology and 16 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in R. Lynen's work include Reproductive Health and Contraception (16 papers), Blood groups and transfusion (15 papers) and Global Maternal and Child Health (11 papers). R. Lynen is often cited by papers focused on Reproductive Health and Contraception (16 papers), Blood groups and transfusion (15 papers) and Global Maternal and Child Health (11 papers). R. Lynen collaborates with scholars based in United States, Germany and Sweden. R. Lynen's co-authors include Michael Köhler, Tobias J. Legler, Amy Law, G. Simson, J. Riggert, Andreas Humpe, Eberhard Schleyer, Wolfgang Hiddemann, Wolfgang R. Mayr and Wolfgang Kern and has published in prestigious journals such as The Journal of Immunology, American Journal of Obstetrics and Gynecology and Fertility and Sterility.

In The Last Decade

R. Lynen

43 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Lynen United States 14 248 153 123 101 83 45 528
Christina Stern Austria 14 82 0.3× 93 0.6× 171 1.4× 45 0.4× 46 0.6× 35 545
Hatice Işık Türkiye 11 75 0.3× 113 0.7× 52 0.4× 42 0.4× 9 0.1× 29 420
Mindy Goldman United States 12 39 0.2× 99 0.6× 73 0.6× 20 0.2× 27 0.3× 45 501
B. Byrne Ireland 14 65 0.3× 132 0.9× 323 2.6× 15 0.1× 26 0.3× 49 697
H. H. H. Kanhai Netherlands 15 174 0.7× 128 0.8× 530 4.3× 77 0.8× 10 0.1× 27 734
Romuald Dębski Poland 9 48 0.2× 99 0.6× 69 0.6× 16 0.2× 4 0.0× 61 348
Mary Campbell‐Brown United Kingdom 11 70 0.3× 187 1.2× 257 2.1× 62 0.6× 3 0.0× 20 828
Neena Malhotra India 16 22 0.1× 267 1.7× 162 1.3× 47 0.5× 5 0.1× 41 642
Victoria Snegovskikh United States 13 33 0.1× 163 1.1× 184 1.5× 7 0.1× 23 0.3× 22 523
Joaquím Calaf Spain 17 24 0.1× 301 2.0× 149 1.2× 12 0.1× 6 0.1× 100 852

Countries citing papers authored by R. Lynen

Since Specialization
Citations

This map shows the geographic impact of R. Lynen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Lynen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Lynen more than expected).

Fields of papers citing papers by R. Lynen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Lynen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Lynen. The network helps show where R. Lynen may publish in the future.

Co-authorship network of co-authors of R. Lynen

This figure shows the co-authorship network connecting the top 25 collaborators of R. Lynen. A scholar is included among the top collaborators of R. Lynen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Lynen. R. Lynen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sanders, Jessica N., David K. Turok, Lori M. Gawron, et al.. (2017). Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review. American Journal of Obstetrics and Gynecology. 216(6). 590.e1–590.e8. 19 indexed citations
3.
Bahamondes, Luís, et al.. (2015). Knowledge and attitudes of Latin American obstetricians and gynecologists regarding intrauterine contraceptives. International Journal of Women s Health. 7. 717–717. 11 indexed citations
4.
Law, Amy, Mark A. McCoy, R. Lynen, et al.. (2015). Costs of Newborn Care Following Complications During Pregnancy and Delivery. Maternal and Child Health Journal. 19(9). 2081–2088. 5 indexed citations
5.
Nahum, Gerard G., Andrew M. Kaunitz, K. Rosén, Thomas Schmelter, & R. Lynen. (2015). Ovarian cysts: presence and persistence with use of a 13.5mg levonorgestrel-releasing intrauterine system. Contraception. 91(5). 412–417. 17 indexed citations
6.
Law, Amy, Mark A. McCoy, R. Lynen, et al.. (2015). The prevalence of complications and healthcare costs during pregnancy. Journal of Medical Economics. 18(7). 533–541. 36 indexed citations
7.
Laliberté, François, Patrick Lefèbvre, Amy Law, et al.. (2014). Medicaid spending on contraceptive coverage and pregnancy-related care. Reproductive Health. 11(1). 20–20. 6 indexed citations
8.
Castaño, Paula M., Aida Aydemir, Carole Sampson-Landers, & R. Lynen. (2013). The folate status of reproductive-aged women in a randomised trial of a folate-fortified oral contraceptive: dietary and blood assessments. Public Health Nutrition. 17(6). 1375–1383. 6 indexed citations
9.
Nelson, Anita L., Kristina Gemzell‐Danielsson, Lynn Borgatta, et al.. (2012). User satisfaction, ease of placement, and discomfort during placement of two low-dose levonorgestrel contraceptive intrauterine systems (LNG-IUS) in a multicenter, randomized, phase 3 study. Fertility and Sterility. 98(3). S194–S194.
10.
Joish, Vijay N., et al.. (2011). Use of drospirenone/ethinyl estradiol (DRSP/EE) among women with acne reduces acne treatment-related resources. Journal of Medical Economics. 14(6). 681–689. 6 indexed citations
11.
Taylor, Thomas N., Raymond Farkouh, James E. Graham, et al.. (2011). Potential reduction in neural tube defects associated with use of Metafolin-fortified oral contraceptives in the United States. American Journal of Obstetrics and Gynecology. 205(5). 460.e1–460.e8. 11 indexed citations
12.
13.
Rumpf, K. W., et al.. (2008). Hämolytisch-urämisches Syndrom des Erwachsenen mit T-Kryptantigen-Freilegung*. DMW - Deutsche Medizinische Wochenschrift. 115(34). 1270–1275.
14.
Raddatz, Dirk, et al.. (2003). HFE Genotype and Parameters of Iron Metabolism in German First-Time Blood Donors. Zeitschrift für Gastroenterologie. 41(11). 1069–1076. 16 indexed citations
15.
Humpe, Andreas, R. Lynen, B. Glock, et al.. (1999). A dispermic chimerism in a 2-year-old Caucasian boy. Annals of Hematology. 78(9). 431–434. 20 indexed citations
16.
Legler, Tobias J., Stefan Eber, M. Lakomek, et al.. (1999). Application of RHD and RHCE genotyping for correct blood group determination in chronically transfused patients. Transfusion. 39(8). 852–855. 48 indexed citations
17.
Legler, Tobias J., Imma Fischer, G. Simson, et al.. (1997). Frequency and causes of refractoriness in multiply transfused patients. Annals of Hematology. 74(4). 185–189. 96 indexed citations
18.
Köhler, Michael, Tobias J. Legler, R. Lynen, et al.. (1996). Flow cytometric detection of platelet‐reactive antibodies and application in platelet crossmatching. Transfusion. 36(3). 250–255. 33 indexed citations
19.
Lynen, R., et al.. (1995). Flow Cytometric Analyses of the Subclasses of Red Cell IgG Antibodies. Vox Sanguinis. 69(2). 126–130. 24 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina Stern Breakdown of academic impact, for papers by Hatice Işık Breakdown of academic impact, for papers by Mindy Goldman Breakdown of academic impact, for papers by B. Byrne Breakdown of academic impact, for papers by H. H. H. Kanhai Breakdown of academic impact, for papers by Romuald Dębski Breakdown of academic impact, for papers by Mary Campbell‐Brown Breakdown of academic impact, for papers by Neena Malhotra Breakdown of academic impact, for papers by Victoria Snegovskikh Breakdown of academic impact, for papers by Joaquím Calaf
Rankless by CCL
2026